The article you requested is
Review of Treatments That Can Ameliorate Nonadherence in Patients With Schizophrenia.
J Clin Psychiatry 2006;67(suppl 5):9-14
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Nonadherence to medication is one of the major problems in treating patients with schizophrenia.
Clinicians can use a variety of assessment strategies to identify patients who are nonadherent,
although none of these is completely reliable. Interventions to improve adherence include psychosocial
strategies, second-generation oral antipsychotics, and long-acting injectable antipsychotics. Because
of the potential for reduced relapse and rehospitalization rates and the availability of second–generation antipsychotics in injectable form, a case is made for using long-acting injectable
second-generation antipsychotics, when appropriate, to treat patients with schizophrenia.